Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Expanded Prostate Cancer Index Composite

Known as: EPIC, Expanded Prostate Cancer Index Composite (EPIC) 
A self-administered questionnaire designed to evaluate patient function and bother after prostate cancer treatment.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
Importance Understanding the adverse effects of contemporary approaches to localized prostate cancer treatment could inform… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
2016
Highly Cited
2016
Background:Current data on the use of irreversible electroporation (IRE) in the treatment of prostate cancer (PCa) is limited. We… Expand
  • table 1
  • table 2
  • table 5
  • table 3
  • table 4
Highly Cited
2015
Highly Cited
2015
Summary Background Patient-reported outcomes (PROs) might detect more toxic effects of radiotherapy than do clinician-reported… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Highly Cited
2013
Highly Cited
2013
PURPOSE To evaluate the early and late health-related quality of life (QOL) outcomes among prostate cancer patients following… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
Highly Cited
2012
Highly Cited
2012
Summary Background Radical whole-gland therapy can lead to significant genitourinary and rectal side-effects for men with… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Highly Cited
2012
Highly Cited
2012
Recent reports using extreme hypofractionated regimens in the treatment of low‐risk prostate adenocarcinoma have been encouraging… Expand
Highly Cited
2012
Highly Cited
2012
PURPOSE There are multiple treatment options for favorable-risk prostate cancer. High-dose-rate (HDR) brachytherapy as a… Expand
Highly Cited
2011
Highly Cited
2011
PURPOSE Measuring the health related quality of life of patients with prostate cancer in routine clinical practice is hindered by… Expand
Highly Cited
2011
Highly Cited
2011
Study Type – Therapy (outcomes research) Level of Evidence 2c 
Highly Cited
2008
Highly Cited
2008
PURPOSE To compare treatment impact on health-related quality of life (HRQL) in patients with localized prostate cancer, from… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1